CID 10171351

4-(1h-1,3-benzodiazol-2-yl)-1-methyl-1h-pyrazol-5-amine

Structural Information

Molecular Formula
C11H11N5
SMILES
CN1C(=C(C=N1)C2=NC3=CC=CC=C3N2)N
InChI
InChI=1S/C11H11N5/c1-16-10(12)7(6-13-16)11-14-8-4-2-3-5-9(8)15-11/h2-6H,12H2,1H3,(H,14,15)
InChIKey
UOKZBKZOSOVCSP-UHFFFAOYSA-N
Compound name
4-(1H-benzimidazol-2-yl)-2-methylpyrazol-3-amine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

3
Patents

213.10144 Da
Monoisotopic Mass

1.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 214.10872 145.3
[M+Na]+ 236.09066 157.1
[M-H]- 212.09416 147.8
[M+NH4]+ 231.13526 162.5
[M+K]+ 252.06460 151.7
[M+H-H2O]+ 196.09870 136.7
[M+HCOO]- 258.09964 167.3
[M+CH3COO]- 272.11529 158.2
[M+Na-2H]- 234.07611 150.2
[M]+ 213.10089 145.2
[M]- 213.10199 145.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe